Rafarma Pharmaceuticals Stock Market Value
| RAFA Stock | USD 0.09 0.03 47.54% |
| Symbol | Rafarma |
Rafarma Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rafarma Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rafarma Pharmaceuticals.
| 11/16/2024 |
| 12/16/2024 |
If you would invest 0.00 in Rafarma Pharmaceuticals on November 16, 2024 and sell it all today you would earn a total of 0.00 from holding Rafarma Pharmaceuticals or generate 0.0% return on investment in Rafarma Pharmaceuticals over 30 days. Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, an... More
Rafarma Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rafarma Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rafarma Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 15.38 | |||
| Information Ratio | 0.1108 | |||
| Maximum Drawdown | 77.78 | |||
| Value At Risk | (23.33) | |||
| Potential Upside | 33.33 |
Rafarma Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rafarma Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rafarma Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Rafarma Pharmaceuticals historical prices to predict the future Rafarma Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0948 | |||
| Jensen Alpha | 1.65 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.1054 | |||
| Treynor Ratio | 2.48 |
Rafarma Pharmaceuticals Backtested Returns
Rafarma Pharmaceuticals is out of control given 3 months investment horizon. Rafarma Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.16, which implies the firm had a 0.16% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.34% are justified by taking the suggested risk. Use Rafarma Pharmaceuticals Coefficient Of Variation of 850.13, semi deviation of 9.7, and Risk Adjusted Performance of 0.0948 to evaluate company specific risk that cannot be diversified away. Rafarma Pharmaceuticals holds a performance score of 12 on a scale of zero to a hundred. The company holds a Beta of 0.69, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Rafarma Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Rafarma Pharmaceuticals is expected to be smaller as well. Use Rafarma Pharmaceuticals treynor ratio, downside variance, and the relationship between the total risk alpha and value at risk , to analyze future returns on Rafarma Pharmaceuticals.
Auto-correlation | 0.79 |
Good predictability
Rafarma Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Rafarma Pharmaceuticals time series from 16th of November 2024 to 1st of December 2024 and 1st of December 2024 to 16th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rafarma Pharmaceuticals price movement. The serial correlation of 0.79 indicates that around 79.0% of current Rafarma Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Rafarma Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Rafarma Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Rafarma Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Rafarma Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Rafarma Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Rafarma Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Rafarma Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Rafarma Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Rafarma Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Rafarma Pharmaceuticals Lagged Returns
When evaluating Rafarma Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Rafarma Pharmaceuticals pink sheet have on its future price. Rafarma Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Rafarma Pharmaceuticals autocorrelation shows the relationship between Rafarma Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Rafarma Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Rafarma Pink Sheet
Rafarma Pharmaceuticals financial ratios help investors to determine whether Rafarma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rafarma with respect to the benefits of owning Rafarma Pharmaceuticals security.